COVID-19 and Pulmonary Mycobacterium Tuberculosis Coinfection

Overview

Journal Oman Med J

Specialty General Medicine

Date 2021 Oct 11

PMID 34631157

Citations 8

Authors

Redha Al Lawati

Nasser Al Busaidi

Rashid Al Umairi

Merah Al Busaidy

Hanan Hamed Al Naabi

Faryal Khamis

Affiliations

Soon will be listed here.

Abstract

The Coronavirus disease-2019 (COVID-19) outbreak was classified as a global pandemic by the World Health Organization on 11 March 2020. It is caused by the novel severe acute respiratory syndrome coronavirus 2. The virus affects mainly the human respiratory system. (TB) is another respiratory infection known to affect humans and may share joint clinical presentations and risk factors with COVID-19 infection. Therefore, clinicians must have a high index of suspicion that the two infections might coexist so that there is no delay in diagnosis and starting the appropriate treatment. There are few case reports about TB and COVID-19 coinfection. The first case report ever was from China and there have been a few others around the world. Here, we report two cases of coexisting COVID-19 and newly diagnosed pulmonary TB infection in Oman.

Citing Articles

A cooperativity between virus and bacteria during respiratory infections.

Lalbiaktluangi C, Yadav M, Singh P, Singh A, Iyer M, Vellingiri B Front Microbiol. 2023; 14:1279159.

PMID: 38098657 PMC: 10720647. DOI: 10.3389/fmicb.2023.1279159.

COVID-19 and pulmonary Tubercuiosis coinfection: three case reports from Iran.

Nasiri M, Shakibaei S Indian J Tuberc. 2023; 70(4):497-500.

PMID: 37968057 PMC: 10066582. DOI: 10.1016/j.ijtb.2023.03.021.

Prevalence of tuberculosis/COVID-19 co-infection and factors associated with SARS-CoV-2 infection in pulmonary tuberculosis patients at a respiratory diseases center: a cross-sectional study.

Endale Mangamba L, Sike C, Tochie J, Dalle G, Nkouagmi N, Balkissou A Pan Afr Med J. 2023; 44:204.

PMID: 37484595 PMC: 10362651. DOI: 10.11604/pamj.2023.44.204.38541.

Using a multiplex serological assay to estimate time since SARS-CoV-2 infection and past clinical presentation in malagasy patients.

Ndiaye M, Rasoloharimanana L, Razafimahatratra S, Ratovoson R, Rasolofo V, Ranaivomanana P Heliyon. 2023; 9(6):e17264.

PMID: 37332901 PMC: 10263216. DOI: 10.1016/j.heliyon.2023.e17264.

Leading Pathogens Involved in Co-Infection and Super-Infection with COVID-19: Forensic Medicine Considerations after a Systematic Review and Meta-Analysis.

Scendoni R, Bury E, Ribeiro I, Cingolani M, Cameriere R, De Benedictis A Pathogens. 2023; 12(5).

PMID: 37242315 PMC: 10222087. DOI: 10.3390/pathogens12050646.

References

Stochino C, Villa S, Zucchi P, Parravicini P, Gori A, Raviglione M . Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital. Eur Respir J. 2020; 56(1). PMC: 7263070. DOI: 10.1183/13993003.01708-2020. View

Liu W, Fontanet A, Zhang P, Zhan L, Xin Z, Tang F . Pulmonary tuberculosis and SARS, China. Emerg Infect Dis. 2006; 12(4):707-9. PMC: 3294680. View

Wong C, Wong K, Law T, Shum T, Li Y, Pang W . Tuberculosis in a SARS outbreak. J Chin Med Assoc. 2005; 67(11):579-82. View

Low J, Lee C, Leo Y, Low J, Lee C, Leo Y . Severe acute respiratory syndrome and pulmonary tuberculosis. Clin Infect Dis. 2004; 38(12):e123-5. PMC: 7107818. DOI: 10.1086/421396. View

Mousquer G, Peres A, Fiegenbaum M . Pathology of TB/COVID-19 Co-Infection: The phantom menace. Tuberculosis (Edinb). 2020; 126:102020. PMC: 7669479. DOI: 10.1016/j.tube.2020.102020. View

Alfaraj S, Al-Tawfiq J, Altuwaijri T, Memish Z . Middle East Respiratory Syndrome Coronavirus and Pulmonary Tuberculosis Coinfection: Implications for Infection Control. Intervirology. 2017; 60(1-2):53-55. PMC: 7179530. DOI: 10.1159/000477908. View

Rothan H, Byrareddy S . The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020; 109:102433. PMC: 7127067. DOI: 10.1016/j.jaut.2020.102433. View

Khamis F, Al-Zakwani I, Al Naamani H, Al Lawati S, Pandak N, Omar M . Clinical characteristics and outcomes of the first 63 adult patients hospitalized with COVID-19: An experience from Oman. J Infect Public Health. 2020; 13(7):906-913. PMC: 7832725. DOI: 10.1016/j.jiph.2020.06.002. View

Crisan-Dabija R, Grigorescu C, Pavel C, Artene B, Popa I, Cernomaz A . Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes. Can Respir J. 2020; 2020:1401053. PMC: 7479474. DOI: 10.1155/2020/1401053. View

10.

Yousaf Z, Khan A, Chaudhary H, Mushtaq K, Parengal J, Aboukamar M . Cavitary pulmonary tuberculosis with COVID-19 coinfection. IDCases. 2020; 22:e00973. PMC: 7521360. DOI: 10.1016/j.idcr.2020.e00973. View

11.

Khodamoradi Z, Moghadami M, Lotfi M . Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran. Arch Iran Med. 2020; 23(4):239-243. DOI: 10.34172/aim.2020.04. View

12.

He G, Wu J, Shi J, Dai J, Gamber M, Jiang X . COVID-19 in tuberculosis patients: A report of three cases. J Med Virol. 2020; 92(10):1802-1806. PMC: 7267258. DOI: 10.1002/jmv.25943. View

13.

Cox M, Loman N, Bogaert D, OGrady J . Co-infections: potentially lethal and unexplored in COVID-19. Lancet Microbe. 2020; 1(1):e11. PMC: 7195315. DOI: 10.1016/S2666-5247(20)30009-4. View

14.

Yezli S, Memish Z . Tuberculosis in Saudi Arabia: prevalence and antimicrobial resistance. J Chemother. 2012; 24(1):1-5. DOI: 10.1179/1120009X12Z.0000000001. View

15.

Shereen M, Khan S, Kazmi A, Bashir N, Siddique R . COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020; 24:91-98. PMC: 7113610. DOI: 10.1016/j.jare.2020.03.005. View

16.

Abri S, Kowada A, Yaqoubi F, Al Khalili S, Ndunda N, Petersen E . Cost-effectiveness of IGRA/QFT-Plus for TB screening of migrants in Oman. Int J Infect Dis. 2020; 92S:S72-S77. DOI: 10.1016/j.ijid.2020.03.010. View

17.

Gandhi R, Lynch J, Del Rio C . Mild or Moderate Covid-19. N Engl J Med. 2020; 383(18):1757-1766. DOI: 10.1056/NEJMcp2009249. View

18.

Tadolini M, Codecasa L, Garcia-Garcia J, Blanc F, Borisov S, Alffenaar J . Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J. 2020; 56(1). PMC: 7251245. DOI: 10.1183/13993003.01398-2020. View

19.

Narasimhan P, Wood J, MacIntyre C, Mathai D . Risk factors for tuberculosis. Pulm Med. 2013; 2013:828939. PMC: 3583136. DOI: 10.1155/2013/828939. View

20.

Motta I, Centis R, DAmbrosio L, Garcia-Garcia J, Goletti D, Gualano G . Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology. 2020; 26(4):233-240. PMC: 7221402. DOI: 10.1016/j.pulmoe.2020.05.002. View